Telomir Announces Peer-Reviewed Publication Demonstrating Telomir-Zn Suppresses Tumor Growth in TNBC and Prostate Cancer Models

Data ReadoutpositiveTelomir-ZnPositive

AI Analysis

Summary

Telomir announced a peer-reviewed publication demonstrating that Telomir-Zn suppresses tumor growth through iron modulation in preclinical models of triple-negative breast cancer and prostate cancer.

Outcome Details

Peer-reviewed publication demonstrates Telomir-Zn suppresses tumor growth through iron modulation in TNBC and prostate cancer models

Importance:4/10

Sentiment:

0.60

PreclinicalCancerTNBCProstate CancerPublicationPeer-Reviewed

Read the original article

Published by GlobeNewswire Clinical Studies on August 10, 2026 12:00 PM

Read Original